During the past decade, Austin Rheumatology Research conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Austin Rheumatology Research" #1 sponsor was "Rigel Pharmaceuticals" with 3 trials, followed by "Genentech, Inc." with 1 trials sponsored, "Merrimack Pharmaceuticals" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Targeted Genetics Corporation" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Austin Rheumatology Research" #1 collaborator was "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Austin Rheumatology Research" are "Rheumatoid Arthritis" (6 trials), "Arthritis, Rheumatoid" (2 trials), "Ankylosing Spondylitis" (1 trials) and "Arthritis, Psoriatic" (1 trials). Many other conditions were trialed in "Austin Rheumatology Research" in a lesser frequency.

Most popular intervention types in "Austin Rheumatology Research" are "Drug" (7 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Fostamatinib disodium (R935788)" (2 trials), "CP-690,550" (1 trials), "Disease-modifying antirheumatic drug" (1 trials) and "Leflunomide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Austin Rheumatology Research" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Austin Rheumatology Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Austin Rheumatology Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Austin Rheumatology Research, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".